Natural history of hepatitis C infection: a concise review.
نویسنده
چکیده
Chronic hepatitis C virus (HCV)b infection is a major public health problem, affecting over 2.7 million individuals in the U.S. and over 170 million worldwide [1, 2]. In the United States, HCV infection is the most common cause of chronic liver disease, accounts for 8,000 to 10,000 deaths annually, and is the leading indication for liver transplantation [3]. Since the initial discovery of HCV virus as the causative agent of non-A, non-B (NANB) hepatitis by Choo and colleagues in 1989 [4], significant advances have been made in our understanding of its epidemiology, pathogenesis, diagnosis, and therapy. Increased understanding of the natural history of chronic infection will be essential in any effort to further elucidate pathogenetic mechanisms, predict clinical outcomes, and identify those patients for whom treatment is beneficial. Acute infection with HCV virus is usually asymptomatic, and therefore infrequently diagnosed during this early period. Although up to one-third of patients may develop mild flu-like symptoms or jaundice, fulminant liver failure is very rare [5]. Despite vigorous humoral and cellmediated immune responses by the host, approximately 85 percent of patients fail to achieve spontaneous recovery and thus develop chronic infection, defined as a positive HCV antibody and RNA at six months. Chronic infection is typically characterized by a prolonged asymptomatic period, but will eventually lead to chronic hepatitis, cirrhosis, and hepatocellular carcinoma in 70 percent, 20 percent, and 4 percent of cases, respectively [6]. Mechanisms for HCV persistence remain unclear, but may involve viral mutation during replication, persistence in extrahepatic tissues, or formation of quasispecies that escape host immune response [7-8]. The natural history of HCV infection has been difficult to study. Accurate determination requires a well-defined time of disease onset and frequent, prospective monitoring of clinico-pathologic outcomes over the course of infection without therapeutic intervention, ideally with a matched control group for comparison.
منابع مشابه
Hepatitis B Virus Infection in Patients with Blood Disorders: A Concise Review in Pediatric Study
Childhood Hepatitis B virus (HBV) infection causes both medical and public health challenges. Infants who acquire HBV parentally have up to 90% risk of developing chronic HBV infection. It is now estimated that approximately 10% of worldwide cancers are attributable to viral infection, with the vast majority (>85 %) occurring in the developing world. In this distribution, elevated rate and prev...
متن کاملThe challenge of hepatitis C in the HIV-infected person.
Hepatitis C virus (HCV) coinfection occurs in an estimated one quarter of HIV-infected persons in Europe, Australia, and the United States. As use of highly active antiretroviral drugs has markedly reduced opportunistic infections, HCV-related liver disease has emerged as a leading cause of death. HIV infection adversely affects both the natural history and the treatment of hepatitis C. Because...
متن کاملTreatment of Hepatitis C Virus Infection and Associated Vascular Complications: A Literature Review
Interferon (IFN)-based therapy, the cornerstone for treatment of hepatitis C virus (HCV) infection, is generally considered to be the single most effective treatment strategy for this infection. Although most adverse effects of IFN therapy respond very well to the cessation of this drug, there are reports of serious irreversible adverse effects. This review article evaluates the adverse effects...
متن کاملA Review of the Natural History of Chronic Hepatitis C Infection – N A J Med Sci
The burden of chronic hepatitis C infection worldwide is significant. Approximately 4.1 million people in the United States have anti-HCV antibodies. The prevalence worldwide varies, but reaches greater than 3.5% in some regions (North African, East Asia). The burden of hepatitis C virus is reflected in the morbidity and mortality of this disease, as well as the societal costs. The morbidity an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Yale Journal of Biology and Medicine
دوره 74 شماره
صفحات -
تاریخ انتشار 2001